Paratek Pharmaceuticals to be Acquired by Gurnet Point Capital and Novo Holdings

Transaction Provides Paratek Shareholders with Immediate Value and Liquidity

Reflects Potential Value of $3.00 per Share of Common Stock, Including Upfront Cash Payment of $2.15 per Share and a Contingent Value Right of $0.85 on Achievement of a Commercial Milestone

Read more at globenewswire.com